(Q84130046)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585384%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

meta-analysis

0 references

title

Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585384%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

main subject

hepatocellular carcinoma

1 reference

Shushan Yan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585384%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Donghua Xu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585384%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Beicheng Sun

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585384%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

15 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585384%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585384%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585384%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585384%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

3026-3031

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22585384%20AND%20SRC:MED&resulttype=core&format=json

Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies

1 February 2020

cites work

1 reference

12 December 2020

Radiofrequency ablation with or without transcather arterial chemoembolization for management of hepatocellular carcinoma

1 reference

12 December 2020

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

1 reference

12 December 2020

[Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation]

1 reference

12 December 2020

Loco-regional treatment of hepatocellular carcinoma

1 reference

12 December 2020

Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity

1 reference

12 December 2020

Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial

1 reference

12 December 2020

Meta-analysis in clinical trials

1 reference

12 December 2020

Intraoperative radiofrequency thermal ablation combined with portal vein infusion chemotherapy and transarterial chemoembolization for unresectable HCC

1 reference

12 December 2020

Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone

1 reference

12 December 2020

Surgical treatment of hepatocellular carcinoma: expert consensus statement

1 reference

12 December 2020

Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment?

1 reference

12 December 2020

Percutaneous radiofrequency ablation combined with other minimally invasive treatments for recurrent hepatocellular carcinoma after hepatectomy

1 reference

12 December 2020

Grading quality of evidence and strength of recommendations

1 reference

12 December 2020

Hepatocellular carcinoma: A global view.

1 reference

12 December 2020

Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma

1 reference

12 December 2020

Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization

1 reference

12 December 2020

A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma.

1 reference

12 December 2020

Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis

1 reference

12 December 2020

TACE combined with PEI versus TACE alone in the treatment of HCC: a meta-analysis

1 reference

12 December 2020

Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone

1 reference

12 December 2020

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

12 December 2020

Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC

1 reference

12 December 2020

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

1 reference

12 December 2020

Locoregional therapy for hepatocellular carcinoma

1 reference

12 December 2020

Combination therapy of radiofrequency ablation and transarterial chemoembolization in recurrent hepatocellular carcinoma after hepatectomy compared with single treatment.

1 reference

12 December 2020

Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis

1 reference

12 December 2020

Meta-analysis of individual patient data from randomized trials: a review of methods used in practice.

1 reference

12 December 2020